IMGN insider transaction filings
ImmunoGen, Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-02-12. Screen IMGN transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for IMGN between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — ImmunoGen, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-02-12 | 4 | Kalofonos Isabel — SVP & CHIEF COMMERCIAL OFFICER | Disposition to issuer (D): 284,250 (derivative) · Disposition to issuer (D): 47,375 (derivative) · Disposition to issuer (D): 19,458 (derivative) | EDGAR |
| 2024-02-12 | 4 | White Lauren — SVP, CFO AND PFO | Disposition to issuer (D): 295,975 (derivative) · Disposition to issuer (D): 51,625 (derivative) · Disposition to issuer (D): 19,519 (derivative) | EDGAR |
| 2024-02-12 | 4 | Lentini Renee — VP & PRIN ACCTG OFFICER | Disposition to issuer (D): 14,723 · Disposition to issuer (D): 39,370 (derivative) · Disposition to issuer (D): 8,250 (derivative) · Disposition to issuer (D): 6,555 (derivative) · Disposition to issuer (D): 12,625 (derivative) · Disposition to issuer (D): 25,250 (derivative) · +3 more | EDGAR |
| 2024-02-12 | 4 | Coen Stacy Ann — SVP & CHIEF BUSINESS OFFICER | Disposition to issuer (D): 73,274 · Disposition to issuer (D): 150,610 (derivative) · Disposition to issuer (D): 303,465 (derivative) · Disposition to issuer (D): 258,195 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 28,700 (derivative) · +1 more | EDGAR |
| 2024-02-12 | 4 | Char Daniel — SVP & CHIEF LEGAL OFFICER | Disposition to issuer (D): 1,000 · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 22,825 (derivative) | EDGAR |
| 2024-02-12 | 4 | VASCONCELLES MICHAEL — EVP R&D & MEDICAL AFFAIRS | Disposition to issuer (D): 1,327 · Disposition to issuer (D): 960,000 (derivative) · Disposition to issuer (D): 50,515 (derivative) | EDGAR |
| 2024-02-12 | 4 | McCain Tracey L — Director | Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 50,303 (derivative) · Disposition to issuer (D): 19,597 (derivative) · Disposition to issuer (D): 25,556 (derivative) · Disposition to issuer (D): 44,000 (derivative) | EDGAR |
| 2024-02-12 | 4 | Thackray Helen M. — Director | Disposition to issuer (D): 3,074 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 40,932 (derivative) · Disposition to issuer (D): 44,000 (derivative) · Disposition to issuer (D): 32,066 (derivative) · Disposition to issuer (D): 19,597 (derivative) | EDGAR |
| 2024-02-12 | 4 | Enyedy Mark J — CHIEF EXECUTIVE OFFICER, Director | Disposition to issuer (D): 584,397 · Disposition to issuer (D): 102,466 (derivative) · Disposition to issuer (D): 140,357 (derivative) · Disposition to issuer (D): 196,875 (derivative) · Disposition to issuer (D): 925,000 (derivative) · Disposition to issuer (D): 1,100,000 (derivative) · +2 more | EDGAR |
| 2024-02-12 | 4 | Arbuckle Stuart A — Director | Disposition to issuer (D): 5,381 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 63,000 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 15,800 (derivative) · +5 more | EDGAR |
| 2024-02-12 | 4 | Goldberg Mark Alan — Director | Disposition to issuer (D): 60,720 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 160,350 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +7 more | EDGAR |
| 2024-02-12 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Disposition to issuer (D): 21,039 · Disposition to issuer (D): 35,871 (derivative) · Disposition to issuer (D): 121,905 (derivative) · Disposition to issuer (D): 115,273 (derivative) · Disposition to issuer (D): 140,400 (derivative) · Disposition to issuer (D): 87,500 (derivative) · +7 more | EDGAR |
| 2024-02-12 | 4 | Peterson Kristine — Director | Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 74,954 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +4 more | EDGAR |
| 2024-02-12 | 4 | Wallace Richard John — Director | Disposition to issuer (D): 10,000 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 102,326 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +7 more | EDGAR |
| 2024-02-12 | 4 | MITCHELL DEAN J — Director | Disposition to issuer (D): 103,000 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 142,667 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +3 more | EDGAR |
| 2024-02-12 | 4 | MCCLUSKI STEPHEN C — Director | Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 105,458 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +6 more | EDGAR |
| 2024-02-06 | 4 | Lentini Renee — VP & PRIN ACCTG OFFICER | Option exercise (M): 8,435 @ $0 · Sale (S): 2,631 @ $29.30 · Option exercise (M): 8,435 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | Coen Stacy Ann — SVP & CHIEF BUSINESS OFFICER | Option exercise (M): 14,350 @ $0 · Sale (S): 4,583 @ $29.30 · Option exercise (M): 14,350 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | Enyedy Mark J — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 51,234 @ $0 · Sale (S): 20,107 @ $29.28 · Option exercise (M): 51,234 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Option exercise (M): 29,640 @ $0 · Sale (S): 12,027 @ $29.30 · Option exercise (M): 21,840 (derivative) @ $0 · Option exercise (M): 7,800 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Kalofonos Isabel — SVP & CHIEF COMMERCIAL OFFICER | Grant/award (A): 19,458 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | White Lauren — SVP, CFO AND PFO | Grant/award (A): 19,519 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Lentini Renee — VP & PRIN ACCTG OFFICER | Grant/award (A): 10,139 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Coen Stacy Ann — SVP & CHIEF BUSINESS OFFICER | Grant/award (A): 39,293 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Char Daniel — SVP & CHIEF LEGAL OFFICER | Grant/award (A): 22,825 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | VASCONCELLES MICHAEL — EVP R&D & MEDICAL AFFAIRS | Grant/award (A): 50,515 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Enyedy Mark J — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 140,357 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Grant/award (A): 21,364 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Option exercise (M): 58,900 @ $4.83 · Option exercise (M): 2,667 @ $5.75 · Option exercise (M): 126,100 @ $5.25 · Sale (S): 187,667 @ $29.64 · Option exercise (M): 58,900 (derivative) @ $0 · Option exercise (M): 2,667 (derivative) @ $0 · +1 more | EDGAR |
| 2024-01-03 | 4 | Lentini Renee — VP & PRIN ACCTG OFFICER | Grant/award (A): 467 @ $16.01 | EDGAR |
| 2024-01-03 | 4 | Coen Stacy Ann — SVP & CHIEF BUSINESS OFFICER | Option exercise (M): 30,000 @ $5.32 · Grant/award (A): 367 @ $16.01 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | VASCONCELLES MICHAEL — EVP R&D & MEDICAL AFFAIRS | Grant/award (A): 1,327 @ $16.01 | EDGAR |
| 2024-01-03 | 4 | Thackray Helen M. — Director | Grant/award (A): 252 @ $29.65 | EDGAR |
| 2024-01-03 | 4 | Arbuckle Stuart A — Director | Grant/award (A): 442 @ $29.65 | EDGAR |
| 2024-01-03 | 4 | Goldberg Mark Alan — Director | Grant/award (A): 569 @ $29.65 | EDGAR |
| 2024-01-03 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Grant/award (A): 615 @ $16.01 | EDGAR |
| 2023-12-27 | 4 | Lentini Renee — VP & PRIN ACCTG OFFICER | Option exercise (M): 15,000 @ $0 · Sale (S): 6,548 @ $29.74 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Wingrove Theresa — SVP OF REGULATORY AFFAIRS | Option exercise (M): 27,788 @ $4.55 · Option exercise (M): 89,657 @ $5.32 · Sale (S): 117,445 @ $29.40 · Option exercise (M): 27,788 (derivative) @ $0 · Option exercise (M): 89,657 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4/A | MITCHELL DEAN J — Director | Option exercise (M): 10,000 @ $14.70 | EDGAR |
Recent 8-K events — ImmunoGen, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-02-12 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-01-31 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-01-29 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-01-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-01-08 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IMGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →